Fertility drugs and ovarian cancer

被引:13
作者
Artini, PG
Fasciani, A
Cela, V
Battaglia, C
deMicheroux, AA
DAmbrogio, G
Genazzani, AR
机构
[1] Dept. of Obstetrics and Gynecology, Center for Assisted Reproduction, University of Pisa, Pisa
[2] Dept. of Obstetrics and Gynecology, University of Modena, Modena
[3] Dept. of Obstetrics and Gynecology, Center for Assisted Reproduction, University of Pisa, 56100 Pisa
关键词
infertility; fertility treatment; ovarian cancer; epidemiology;
D O I
10.3109/09513599709152318
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent case reports of ovarian cancer associated with infertility treatment raise the question of a possible etiopathogenetic role of fertility drugs in ovarian cancer. In this paper, the possible relationship between infertility treatment and ovarian cancer is reviewed with respect to the epidemiological and pathogenetic profiles of ovarian cancer and the potential risk factors associated with fertility drugs; a case report review and a critical reappraisal are also provided within this article. Currently available data in the literature, from epidemiological studies and case reports, suggest that a direct causal effect of infertility treatment on ovarian cancer seems unlikely. Since infertile women are likely to have a higher risk for the development of ovarian cancer, and the role of fertility drugs in the etiopathogenesis of ovarian carcinoma is not established, a close clinical examination of infertile patients before, during and after infertility treatment is recommended. Moreover, further investigation is required to resolve the question of the possible association between fertility drugs and ovarian cancer through large prospective epidemiological or retrospective case-control studies.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 91 条
  • [1] PARITY, AGE AT FIRST CHILDBIRTH, AND RISK OF OVARIAN-CANCER
    ADAMI, HO
    HSIEH, CC
    LAMBE, M
    TRICHOPOULOS, D
    LEON, D
    PERSSON, I
    EKBOM, A
    JANSON, PO
    [J]. LANCET, 1994, 344 (8932) : 1250 - 1254
  • [2] MASSIVE HYPERSTIMULATION AND BORDERLINE CARCINOMA OF THE OVARY - A POSSIBLE ASSOCIATION
    ATLAS, M
    MENCZER, J
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1982, 61 (03) : 261 - 263
  • [3] AURE JC, 1971, OBSTET GYNECOL, V37, P1
  • [4] FOLLICULAR STIMULATION AND OVARIAN-CANCER
    BALASCH, J
    BARRI, PN
    [J]. HUMAN REPRODUCTION, 1993, 8 (07) : 990 - 996
  • [5] UTERINE AND OVARIAN-CARCINOMA IN A PATIENT RECEIVING GONADOTROPIN THERAPY - CASE-REPORT
    BAMFORD, PN
    STEELE, SJ
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1982, 89 (11): : 962 - 964
  • [6] METABOLISM OF 7,12-DIMETHYLBENZ(A)ANTHRACENE BY DIFFERENT TYPES OF CELLS IN THE HUMAN-OVARY
    BENGTSSON, M
    HAMBERGER, L
    RYDSTROM, J
    [J]. XENOBIOTICA, 1988, 18 (11) : 1255 - 1270
  • [7] OVARIAN-CARCINOMA MASQUERADING AS OVARIAN HYPERSTIMULATION SYNDROME
    BENHUR, H
    DGANI, R
    LANCET, M
    KATZ, Z
    NISSIM, F
    ROSENMAN, D
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1986, 65 (07) : 813 - 814
  • [8] BIZZI A, 1988, CANCER RES, V48, P6222
  • [9] RISK-FACTORS FOR OVARIAN-CANCER - A CASE CONTROL STUDY
    BOOTH, M
    BERAL, V
    SMITH, P
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (04) : 592 - 598
  • [10] BURGER CW, 1983, HUM REPROD S1, V8, P144